BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38329812)

  • 21. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
    Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
    Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.
    Ballout F; Lu H; Chen L; Sriramajayam K; Que J; Meng Z; Wang TC; Giordano S; Zaika A; McDonald O; Peng D; El-Rifai W
    J Exp Clin Cancer Res; 2022 Sep; 41(1):264. PubMed ID: 36045416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cranberry proanthocyanidins modulate reactive oxygen species in Barrett's and esophageal adenocarcinoma cell lines.
    Weh KM; Aiyer HS; Howell AB; Kresty LA
    J Berry Res; 2016; 6(2):125-136. PubMed ID: 27583064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of refluxate pH values on duodenogastroesophageal reflux-induced esophageal adenocarcinoma.
    Cheng P; Li JS; Gong J; Zhang LF; Chen RZ
    World J Gastroenterol; 2011 Jul; 17(25):3060-5. PubMed ID: 21799654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
    Greene CL; Worrell SG; DeMeester TR
    Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular changes in the esophageal epithelium after a subchronic exposure to cigarette smoke in the presence of bile-acid reflux.
    Aiyer HS; Li Y; Harper N; Myers SR; Martin RC
    Inhal Toxicol; 2011 Apr; 23(5):304-11. PubMed ID: 21506880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Snider EJ; Freedberg DE; Abrams JA
    Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.
    Kunze B; Wein F; Fang HY; Anand A; Baumeister T; Strangmann J; Gerland S; Ingermann J; Münch NS; Wiethaler M; Sahm V; Hidalgo-Sastre A; Lange S; Lightdale CJ; Bokhari A; Falk GW; Friedman RA; Ginsberg GG; Iyer PG; Jin Z; Nakagawa H; Shawber CJ; Nguyen T; Raab WJ; Dalerba P; Rustgi AK; Sepulveda AR; Wang KK; Schmid RM; Wang TC; Abrams JA; Quante M
    Gastroenterology; 2020 Aug; 159(2):575-590. PubMed ID: 32325086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma.
    Chen L; Lu H; Peng D; Cao LL; Ballout F; Srirmajayam K; Chen Z; Bhat A; Wang TC; Capobianco A; Que J; McDonald OG; Zaika A; Zhang S; El-Rifai W
    Gut; 2023 Mar; 72(3):421-432. PubMed ID: 35750470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.
    Gibson MK; Zaidi AH; Davison JM; Sanz AF; Hough B; Komatsu Y; Kosovec JE; Bhatt A; Malhotra U; Foxwell T; Rotoloni CL; Hoppo T; Jobe BA
    Ann Surg; 2013 Jul; 258(1):82-8. PubMed ID: 23108119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications.
    Dan W; Peng L; Yan B; Li Z; Pan F
    Front Microbiol; 2021; 12():791274. PubMed ID: 35126331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
    Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
    World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High yield reproducible rat model recapitulating human Barrett's carcinogenesis.
    Matsui D; Omstead AN; Kosovec JE; Komatsu Y; Lloyd EJ; Raphael H; Kelly RJ; Zaidi AH; Jobe BA
    World J Gastroenterol; 2017 Sep; 23(33):6077-6087. PubMed ID: 28970723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UPEC Colonic-Virulence and Urovirulence Are Blunted by Proanthocyanidins-Rich Cranberry Extract Microbial Metabolites in a Gut Model and a 3D Tissue-Engineered Urothelium.
    Roussel C; Chabaud S; Lessard-Lord J; Cattero V; Pellerin FA; Feutry P; Bochard V; Bolduc S; Desjardins Y
    Microbiol Spectr; 2022 Oct; 10(5):e0243221. PubMed ID: 35972287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
    Omstead AN; Kosovec JE; Matsui D; Martin SA; Smith MA; Aaron Guel D; Kolano J; Komatsu Y; Habib F; Lai C; Christopher K; Kelly RJ; Zaidi AH; Jobe BA
    Cancer Invest; 2018; 36(7):363-370. PubMed ID: 30142016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma.
    Zhou J; Shrestha P; Qiu Z; Harman DG; Teoh WC; Al-Sohaily S; Liem H; Turner I; Ho V
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32650561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.